Dr. Wang’s research program is focused on the application of biomedical engineering to cancer research. His group aims to develop novel cancer diagnostics and therapeutics to improve cancer treatment. His work is high impact and highly innovative and has resulted in 38 patents/patent applications and three biotechnology startup companies. His work has been published in high impact journals such as Nature Nanotechnology, Advanced Materials, and Nature Biotechnology. Because of his research accomplishments, Dr. Wang has been elected as a Fellow of the American Association for the Advancement of Science (AAAS), Fellow of the American Institute for Medical and Biological Engineering (AIMBE), and the American Society for Clinical Investigation (ASCI).